News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
759,494 Results
Type
Article (46774)
Company Profile (303)
Press Release (712399)
Multimedia
Podcasts (110)
Webinars (22)
Section
Business (212280)
Career Advice (2983)
Deals (36853)
Drug Delivery (139)
Drug Development (83747)
Employer Resources (188)
FDA (17134)
Job Trends (15762)
News (359872)
Policy (34384)
Tag
2027 BioCapital Elite (1)
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (4)
Academia (2842)
Academic (1)
Accelerated approval (46)
Adcomms (30)
Allergies (171)
Alliances (51570)
ALS (201)
Alzheimer's disease (1811)
Antibody-drug conjugate (ADC) (438)
Approvals (17458)
Artificial intelligence (649)
Autoimmune disease (256)
Automation (52)
Bankruptcy (373)
Best Places to Work (12141)
BIOSECURE Act (20)
Biosimilars (223)
Biotechnology (195)
Bladder cancer (186)
Brain cancer (76)
Breast cancer (730)
Cancer (5729)
Cardiovascular disease (482)
Career advice (2531)
Career pathing (48)
CAR-T (322)
CDC (64)
Celiac Disease (2)
Cell therapy (853)
Cervical cancer (46)
Clinical research (72284)
Collaboration (2060)
Company closure (4)
Compensation (1343)
Complete response letters (79)
COVID-19 (2861)
CRISPR (108)
C-suite (1106)
Cystic fibrosis (154)
Data (7532)
Decentralized trials (3)
Denatured (36)
Depression (168)
Dermatology (70)
Diabetes (581)
Diagnostics (7198)
Digital health (55)
Diversity (13)
Diversity, equity & inclusion (47)
Drug discovery (313)
Drug pricing (212)
Drug shortages (36)
Duchenne muscular dystrophy (276)
Earnings (93099)
Editorial (69)
Employer branding (23)
Employer resources (166)
Events (124012)
Executive appointments (1111)
FDA (20767)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (33)
Funding (1717)
Gene editing (229)
Generative AI (60)
Gene therapy (695)
GLP-1 (1092)
Government (5027)
Grass and pollen (7)
Guidances (407)
Healthcare (20228)
HIV (80)
Huntington's disease (56)
IgA nephropathy (98)
Immunology and inflammation (292)
Immuno-oncology (91)
Indications (167)
Infectious disease (3210)
Inflammatory bowel disease (213)
Inflation Reduction Act (14)
Influenza (138)
Intellectual property (280)
Interviews (515)
IPO (16994)
IRA (54)
Job creations (3933)
Job search strategy (2109)
JPM (61)
Kidney cancer (20)
Labor market (98)
Layoffs (591)
Leadership (46)
Legal (8368)
Liver cancer (103)
Longevity (31)
Lung cancer (763)
Lymphoma (421)
Machine learning (56)
Management (65)
Manufacturing (988)
MASH (187)
Medical device (14484)
Medtech (14572)
Mergers & acquisitions (21075)
Metabolic disorders (1495)
mRNA (194)
Multiple sclerosis (184)
NASH (21)
Neurodegenerative disease (409)
Neuropsychiatric disorders (112)
Neuroscience (3310)
Neurotech (1)
NextGen: Class of 2026 (7057)
Non-profit (4954)
Now hiring (76)
Obesity (707)
Opinion (321)
Ovarian cancer (208)
Pain (247)
Pancreatic cancer (283)
Parkinson's disease (364)
Partnered (34)
Patents (569)
Patient recruitment (643)
Peanut (62)
People (62277)
Pharmaceutical (67)
Pharmacy benefit managers (35)
Phase 1 (22416)
Phase 2 (31776)
Phase 3 (23806)
Pipeline (7798)
Policy (329)
Postmarket research (2687)
Preclinical (9535)
Press Release (66)
Prostate cancer (292)
Psychedelics (56)
Radiopharmaceuticals (327)
Rare diseases (1060)
Real estate (6260)
Recruiting (76)
Regulatory (26258)
Reports (58)
Research institute (2589)
Resumes & cover letters (475)
Rett syndrome (34)
RNA editing (19)
RSV (94)
Schizophrenia (175)
Series A (284)
Series B (211)
Service/supplier (13)
Sickle cell disease (111)
Special edition (24)
Spinal muscular atrophy (169)
Sponsored (47)
Startups (3825)
State (2)
Stomach cancer (20)
Supply chain (130)
Tariffs (91)
The Weekly (72)
Vaccines (1123)
Venture capital (104)
Weight loss (461)
Women's health (120)
Worklife (24)
Date
Today (25)
Last 7 days (780)
Last 30 days (2589)
Last 365 days (31020)
2026 (10146)
2025 (31005)
2024 (36167)
2023 (41106)
2022 (52297)
2021 (57028)
2020 (55919)
2019 (49018)
2018 (37134)
2017 (33540)
2016 (33229)
2015 (39190)
2014 (32748)
2013 (27852)
2012 (30151)
2011 (30759)
2010 (28794)
Location
Africa (897)
Alabama (94)
Alaska (7)
Arizona (353)
Arkansas (14)
Asia (41922)
Australia (7007)
California (12820)
Canada (3663)
China (1318)
Colorado (558)
Connecticut (562)
Delaware (385)
Europe (93209)
Florida (1939)
Georgia (422)
Hawaii (3)
Idaho (67)
Illinois (1064)
India (92)
Indiana (603)
Iowa (23)
Japan (515)
Kansas (130)
Kentucky (51)
Louisiana (40)
Maine (75)
Maryland (1561)
Massachusetts (9199)
Michigan (359)
Minnesota (715)
Mississippi (7)
Missouri (157)
Montana (34)
Nebraska (29)
Nevada (141)
New Hampshire (87)
New Jersey (3422)
New Mexico (30)
New York (3401)
North Carolina (1660)
North Dakota (8)
Northern California (6348)
Ohio (387)
Oklahoma (26)
Oregon (41)
Pennsylvania (2583)
Puerto Rico (28)
Rhode Island (51)
South America (1286)
South Carolina (86)
South Dakota (2)
Southern California (5062)
Tennessee (208)
Texas (2045)
United States (45718)
Utah (388)
Vermont (1)
Virginia (310)
Washington D.C. (81)
Washington State (1032)
West Virginia (4)
Wisconsin (141)
Wyoming (2)
759,494 Results for "renal care group inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Panoramic Health and West Coast Kidney Institute Launch Concord Cardio-Renal Research Institute to Advance Clinical Trials in Cardio-Renal-Metabolic Disease
April 2, 2026
·
3 min read
Press Releases
SK Life Science, Inc. Launches Epilepsy Connect to Empower Advanced Practice Providers in Epilepsy Care
April 16, 2026
·
6 min read
Government
PhMRA’s long-standing leader Steve Ubl to leave lobby group by year-end
Industry leader Steve Ubl has served as PhRMA’s CEO for more than a decade, the longest tenure of any head of the trade group.
April 9, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Gel4Med Expands Acute-Care Market Access for G4Derm™ Plus Biomimetic Matrix (BMM™) Through Collaboration with Summit Products Group and MiMEDX
February 9, 2026
·
2 min read
Press Releases
Medical Care Technologies Inc. (OTC PINK:MDCE) Highlights Execution Momentum and Expanding AI Pipeline Following Strategic Growth Initiative
April 24, 2026
·
2 min read
Press Releases
Vexev’s VxWave System Successfully Meets Clinical Endpoints in Landmark Study Evaluating Robotic Ultrasound Scanning for Mapping Vascular Access at U.S. Renal Care Dialysis Clinics
November 11, 2025
·
4 min read
Press Releases
HiberCell to Present Preclinical Data Demonstrating the Enhanced Antitumor Activity of HC-7366 in Combination with VEGFR-TKIs in Clear Cell Renal Cell Carcinoma (ccRCC)
April 14, 2026
·
3 min read
Rare diseases
Rare Disease Groups Lobby for Regulatory Expediency as Makary Defends ‘Rigorous’ Approach
This week’s Capitol Hill meetings come on the heels of rejections of ultra-rare disease drugs developed by Biohaven and Saol Therapeutics. Physicians and patient groups implored the FDA to expedite these treatments.
February 27, 2026
·
6 min read
·
Heather McKenzie
Press Releases
Otsuka Medical Devices/Otsuka Pharmaceutical: Paradise Ultrasound Renal Denervation System for the Treatment of Resistant Hypertension, Now Covered by Insurance and Commercially Available in Japan
March 2, 2026
·
3 min read
Press Releases
Merck and Eisai Provide Update on Phase 3 LITESPARK-012 Trial Evaluating First-Line Combination Treatments for Certain Patients With Advanced Renal Cell Carcinoma (RCC)
April 21, 2026
·
19 min read
1 of 75,950
Next
